Filing Details
- Accession Number:
- 0000899243-16-029179
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-16 19:27:21
- Reporting Period:
- 2016-09-14
- Filing Date:
- 2016-09-16
- Accepted Time:
- 2016-09-16 19:27:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520697 | Acadia Healthcare Company Inc. | ACHC | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1299241 | Waud Capital Partners Ii, L.p. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No | |
| 1299294 | Waud Capital Partners Qp Ii, L.p. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No | |
| 1532445 | Waud Capital Partners Ii, L.l.c. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No | |
| 1532459 | Waud Capital Partners Management Ii, L.p. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No | |
| 1532463 | Wcp Fif Ii (Acadia), L.p. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No | |
| 1532464 | Waud Capital Affiliates Ii, L.l.c. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Disposition | 2016-09-14 | 83,861 | $50.19 | 4,617,420 | No | 4 | S | Indirect | See footnotes |
| Common Stock, Par Value $0.01 Per Share | Disposition | 2016-09-15 | 223,640 | $49.24 | 4,393,780 | No | 4 | S | Indirect | See footnotes |
| Common Stock, Par Value $0.01 Per Share | Disposition | 2016-09-16 | 521,033 | $47.74 | 3,872,747 | No | 4 | S | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnotes |
| No | 4 | S | Indirect | See footnotes |
| No | 4 | S | Indirect | See footnotes |
Footnotes
- Represents shares sold in multiple transactions under Rule 144 as follows: (i) 15,785 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 47,664 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 10,084 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 10,328 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II").
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4.
- Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares.
- Represents shares sold in multiple transactions under Rule 144 as follows: (i) 42,095 shares by WCP II, (ii) 127,109 shares by Waud QP II, (iii) 26,893 shares by WCP FIF II and (iv) 27,543 shares by Waud Affiliates II.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4.
- Represents shares sold as follows: (i) 98,073 shares by WCP II, (ii) 296,136 shares by Waud QP II, (iii) 62,655 shares by WCP FIF II and (iv) 64,169 shares by Waud Affiliates II.
- The reported shares are owned of record as follows: (i) 1,141,420 shares by WCP II, (ii) 2,086,697 shares by Waud QP II, (iii) 318,466 shares by WCP FIF II and (iv) 326,164 shares by Waud Affiliates II.
- Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein.
Billionaire Hedge Funds
